search
Back to results

ExeRTiOn2- The Weight Gain Prevention Exercise in Renal Transplant Online Study (ExeRTiOn2)

Primary Purpose

Kidney Transplant; Complications, Weight Gain

Status
Completed
Phase
Not Applicable
Locations
United Kingdom
Study Type
Interventional
Intervention
ExeRTiOn online resource
Sponsored by
King's College Hospital NHS Trust
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional other trial for Kidney Transplant; Complications focused on measuring kidney transplant, weight gain prevention, behavior change techniques, dietary advice, physical activity advice

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • age 18 or above
  • able to provide written consent
  • less than 3 months post kidney transplant
  • access to the internet connected computer, tablet, laptop or smartphone
  • a body mass index greater than or equal to 18.5 (healthy range)

Exclusion Criteria:

  • age < 18
  • current pregnancy
  • unstable medication condition such as uncontrolled angina
  • participation in a recent structured exercise programme in the last 3 months
  • BMI of less than 18.5 (classified as underweight)
  • significant cognitive impairment preventing them from engaging with the online resource
  • unable to complete the resource in English

Sites / Locations

  • Guy's and St Thomas' Hospital
  • King's College Hospital

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

No Intervention

Arm Label

Intervention Group

Control group

Arm Description

This group will receive access to the 12-week kidney transplant specific weight gain prevention online resource (ExeRTiOn online resource). After the 12 weeks, they will be offered the option to continue using the website up until the completion of the study (12 months)

This group will not receive the online resource. They will receive the standard encouragement to follow a healthy diet and perform physical activity during routine transplant follow up appointments.

Outcomes

Primary Outcome Measures

Feasibility- screening of participants
number of participants screened per month, and those unwilling to take part
Feasibility- recruitment of participants into the trial
number of participants recruited per month
Feasibility- proportion of participants willing to be randomized
willingness of participants to be randomized to each group
feasibility- monthly retention of participants over the trial period
number of participants retained per month
feasibility- total retention of participants over the trial period
number of participants retained and at end of study
feasibility-adherence to ExeRTiOn online resource (intervention group)
aim for 60% completion of sessions
feasibility- time taken to complete all study visits
the average time taken to complete study visits will be captured
feasibility- adherence to study visits throughout the trial
the proportion of completed study visits for outcome measures will be calculated
feasibility- safety throughout the trial
the number of hospital admissions (non-elective, or elective staying >24 hours) will be captured
feasibility- qualitative experience of participants using the online resource
individual semi-structured interviews in a purposive sample from the treatment group
feasibility- qualitative experience of participants participation in the trial
individual semi-structured interviews in a purposive sample of study participants

Secondary Outcome Measures

change in body weight in kilograms over the trial
body weight in kilograms will be recorded at the three study visits and the change will be calculated
body mass index over the 12 month trial
body mass index at each 3 study visits
body composition over the 12 month trial
body composition will be measured at each of the 3 study visits
quality of life (self-reported) over the 12 month trial
QOL will be measured by the EQ5D questionnaire at each of the 3 study visits
self reported self-efficacy for nutrition scale over the 12 month trial
self-efficacy for nutrition will be measured via the self-efficacy scale at each of the 3 study visits. The scale has 5 statements/questions. The user selects a number from 1 to 4, with 1 being very uncertain and 4 being very certain for each of the five statements. The highest score (higher self-efficacy) is 20, the lowest score (low self-efficacy) is 5.
self reported self-efficacy for physical exercise scale over the 12 month trial
self-efficacy for physical exercise will be measured via this self-efficacy scale at each of the 3 study visits. The scale has 5 statements/questions. The user selects a number from 1 to 4, with 1 being very uncertain and 4 being very certain for each of the five statements. The highest score (higher self-efficacy) is 20, the lowest score (low self-efficacy) is 5.
Total score self reported fatigue via the Chalder Fatigue Questionnaire over the 12 months
self-reported fatigue will be measured using the Chalder Fatigue scale. It has 11 items, 7 measure physical fatigue and 4 measure mental fatigue. The user rates each question on a likert scoring system 0-3, with the maximum score being 33 (high fatigue).
Physical fatigue (sub-scale) of the Chalder Fatigue Questionnaire over the 12 months
7 of the items measure physical fatigue, the maximum sub score is 21(high physical fatigue)
Mental fatigue (sub-scale) of the Chalder Fatigue Questionnaire over the 12 months
4 of the items measure mental fatigue, the maximum sub score is 12 (high mental fatigue)
arterial stiffness over the 12 month trial
arterial stiffness will be measured by pulse wave velocity
physical function over the 12 month trial
physical function will be assessed by the six minute walk test at each timepoint

Full Information

First Posted
June 18, 2019
Last Updated
August 19, 2021
Sponsor
King's College Hospital NHS Trust
Collaborators
Kidney Research U.K.
search

1. Study Identification

Unique Protocol Identification Number
NCT03996551
Brief Title
ExeRTiOn2- The Weight Gain Prevention Exercise in Renal Transplant Online Study
Acronym
ExeRTiOn2
Official Title
ExeRTiOn2- The Weight Gain Prevention Exercise in Renal Transplant Online Study. A Feasibility Randomised Controlled Trial.
Study Type
Interventional

2. Study Status

Record Verification Date
August 2021
Overall Recruitment Status
Completed
Study Start Date
September 20, 2019 (Actual)
Primary Completion Date
March 22, 2021 (Actual)
Study Completion Date
June 30, 2021 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
King's College Hospital NHS Trust
Collaborators
Kidney Research U.K.

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The primary aim of this trial is to assess the feasibility of a novel online weight gain prevention resource for new kidney transplant recipients at two London transplant clinics. A previous study conducted by the research team titled 'ExeRTiOn' provided usability feedback that led to revisions of this online resource in a purposive sample of kidney transplant recipients (n=11) and transplant multidisciplinary team members (n=6).
Detailed Description
This current study aims to recruit a sample of new kidney transplant recipients (n=50) from two transplant sites in London. Participants will be randomized to either the 12-week kidney transplant specific novel online weight gain prevention resource (n=25) or usual care (n=25). All participants will be assessed at baseline, 12 weeks and 12 months. The primary outcome of this study is feasibility (screening, recruitment, randomization, retention, adherence to the intervention and adherence to the study visits). The research team will also assess the ability to collect measures for a definitive study (body weight, body mass index, body composition, quality of life, self-efficacy, fatigue, arterial stiffness and physical function). A nested qualitative study will capture participant experience at two time points during this 12 month trial. At 3 months semi-structured individual interviews will be conducted in a purposive approximately 6 to 10 of the intervention participants until data saturation is achieved. These interviews will assess the experience of using the online intervention. At 6 months a purposive sample of approximately 16 participants from both groups will complete individual semi-structured interviews to assess the experiences of participating in this trial.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Kidney Transplant; Complications, Weight Gain
Keywords
kidney transplant, weight gain prevention, behavior change techniques, dietary advice, physical activity advice

7. Study Design

Primary Purpose
Other
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
17 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Intervention Group
Arm Type
Experimental
Arm Description
This group will receive access to the 12-week kidney transplant specific weight gain prevention online resource (ExeRTiOn online resource). After the 12 weeks, they will be offered the option to continue using the website up until the completion of the study (12 months)
Arm Title
Control group
Arm Type
No Intervention
Arm Description
This group will not receive the online resource. They will receive the standard encouragement to follow a healthy diet and perform physical activity during routine transplant follow up appointments.
Intervention Type
Behavioral
Intervention Name(s)
ExeRTiOn online resource
Intervention Description
This is a 12-week online resource, specifically designed for new kidney transplant recipients. It includes dietary advice, physical activity advice, and recognized behavior change techniques. The participant will be monitored by a specialist physiotherapist and will receive messages of encouragement a 6 weeks and 12 weeks.
Primary Outcome Measure Information:
Title
Feasibility- screening of participants
Description
number of participants screened per month, and those unwilling to take part
Time Frame
through study completion, an average of 1 year
Title
Feasibility- recruitment of participants into the trial
Description
number of participants recruited per month
Time Frame
through study completion, an average of 1 year
Title
Feasibility- proportion of participants willing to be randomized
Description
willingness of participants to be randomized to each group
Time Frame
through study completion, an average of 1 year
Title
feasibility- monthly retention of participants over the trial period
Description
number of participants retained per month
Time Frame
through study completion, an average of 1 year
Title
feasibility- total retention of participants over the trial period
Description
number of participants retained and at end of study
Time Frame
through study completion, an average of 1 year
Title
feasibility-adherence to ExeRTiOn online resource (intervention group)
Description
aim for 60% completion of sessions
Time Frame
by three months
Title
feasibility- time taken to complete all study visits
Description
the average time taken to complete study visits will be captured
Time Frame
through study completion, an average of 1 year
Title
feasibility- adherence to study visits throughout the trial
Description
the proportion of completed study visits for outcome measures will be calculated
Time Frame
through study completion, an average of 1 year
Title
feasibility- safety throughout the trial
Description
the number of hospital admissions (non-elective, or elective staying >24 hours) will be captured
Time Frame
12 months
Title
feasibility- qualitative experience of participants using the online resource
Description
individual semi-structured interviews in a purposive sample from the treatment group
Time Frame
3 months
Title
feasibility- qualitative experience of participants participation in the trial
Description
individual semi-structured interviews in a purposive sample of study participants
Time Frame
6 months
Secondary Outcome Measure Information:
Title
change in body weight in kilograms over the trial
Description
body weight in kilograms will be recorded at the three study visits and the change will be calculated
Time Frame
baseline, 3 months and 12 months
Title
body mass index over the 12 month trial
Description
body mass index at each 3 study visits
Time Frame
baseline, 3 months, 12 months
Title
body composition over the 12 month trial
Description
body composition will be measured at each of the 3 study visits
Time Frame
baseline, 3 months, 12 months
Title
quality of life (self-reported) over the 12 month trial
Description
QOL will be measured by the EQ5D questionnaire at each of the 3 study visits
Time Frame
baseline, 3 months, 12 months
Title
self reported self-efficacy for nutrition scale over the 12 month trial
Description
self-efficacy for nutrition will be measured via the self-efficacy scale at each of the 3 study visits. The scale has 5 statements/questions. The user selects a number from 1 to 4, with 1 being very uncertain and 4 being very certain for each of the five statements. The highest score (higher self-efficacy) is 20, the lowest score (low self-efficacy) is 5.
Time Frame
baseline, 3 months, 12 months
Title
self reported self-efficacy for physical exercise scale over the 12 month trial
Description
self-efficacy for physical exercise will be measured via this self-efficacy scale at each of the 3 study visits. The scale has 5 statements/questions. The user selects a number from 1 to 4, with 1 being very uncertain and 4 being very certain for each of the five statements. The highest score (higher self-efficacy) is 20, the lowest score (low self-efficacy) is 5.
Time Frame
baseline, 3 months, 12 months
Title
Total score self reported fatigue via the Chalder Fatigue Questionnaire over the 12 months
Description
self-reported fatigue will be measured using the Chalder Fatigue scale. It has 11 items, 7 measure physical fatigue and 4 measure mental fatigue. The user rates each question on a likert scoring system 0-3, with the maximum score being 33 (high fatigue).
Time Frame
baseline, 3 months, 12 months
Title
Physical fatigue (sub-scale) of the Chalder Fatigue Questionnaire over the 12 months
Description
7 of the items measure physical fatigue, the maximum sub score is 21(high physical fatigue)
Time Frame
baseline, 3 months, 12 months
Title
Mental fatigue (sub-scale) of the Chalder Fatigue Questionnaire over the 12 months
Description
4 of the items measure mental fatigue, the maximum sub score is 12 (high mental fatigue)
Time Frame
baseline, 3 months, 12 months
Title
arterial stiffness over the 12 month trial
Description
arterial stiffness will be measured by pulse wave velocity
Time Frame
at baseline, 3 months and 12 months
Title
physical function over the 12 month trial
Description
physical function will be assessed by the six minute walk test at each timepoint
Time Frame
baseline, 3 months, 12 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: age 18 or above able to provide written consent less than 3 months post kidney transplant access to the internet connected computer, tablet, laptop or smartphone a body mass index greater than or equal to 18.5 (healthy range) Exclusion Criteria: age < 18 current pregnancy unstable medication condition such as uncontrolled angina participation in a recent structured exercise programme in the last 3 months BMI of less than 18.5 (classified as underweight) significant cognitive impairment preventing them from engaging with the online resource unable to complete the resource in English
Facility Information:
Facility Name
Guy's and St Thomas' Hospital
City
London
State/Province
UK
ZIP/Postal Code
SE1 9RT
Country
United Kingdom
Facility Name
King's College Hospital
City
London
State/Province
UK
ZIP/Postal Code
SE5 9RS
Country
United Kingdom

12. IPD Sharing Statement

Plan to Share IPD
Undecided
IPD Sharing Plan Description
The research team plans to publish the results in a journal publication. They will include anoymized raw data in the supplementary material
Citations:
PubMed Identifier
35677553
Citation
Castle EM, Dijk G, Asgari E, Shah S, Phillips R, Greenwood J, Bramham K, Chilcot J, Greenwood SA. The Feasibility and User-Experience of a Digital Health Intervention Designed to Prevent Weight Gain in New Kidney Transplant Recipients-The ExeRTiOn2 Trial. Front Nutr. 2022 May 23;9:887580. doi: 10.3389/fnut.2022.887580. eCollection 2022.
Results Reference
derived

Learn more about this trial

ExeRTiOn2- The Weight Gain Prevention Exercise in Renal Transplant Online Study

We'll reach out to this number within 24 hrs